ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,362Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 3001

$1.54M Total Retail Price of All Prescriptions

Rank: 32 out of 3001

663 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 663 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 663 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 17,818 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 940 673 1 1
FUROSEMIDE 887 726 2 6
LEVOTHYROXINE SODIUM 802 606 3 3
LISINOPRIL 751 582 4 2
OMEPRAZOLE 703 428 5 4
WARFARIN SODIUM 576 367 6 12
AMLODIPINE BESYLATE 523 397 7 5
SERTRALINE HCL 437 355 8 20
METOPROLOL TARTRATE 436 409 9 8
GABAPENTIN 434 217 10 14
METFORMIN HCL 432 315 11 9
TRAZODONE HCL 380 185 12 37
TRAMADOL HCL 369 248 13 17
DONEPEZIL HCL 365 357 14 27
HYDROCODONE-ACETAMINOPHEN 309 129 S3 15 7
CITALOPRAM HBR 303 199 16 16
POTASSIUM CHLORIDE 303 244 16 15
HYDROCHLOROTHIAZIDE 286 188 18 10
NAMENDA 271 271 19 40
LANTUS 252 138 20 47
PROAIR HFA 234 100 21 30
CARVEDILOL 233 156 22 25
ATORVASTATIN CALCIUM 228 162 23 11
NEXIUM 218 170 24 23
MIRTAZAPINE 210 166 25 44
KLOR-CON M20 208 174 26 52
CLOPIDOGREL 198 177 27 28
CYMBALTA 185 125 28 53
PRAVASTATIN SODIUM 183 121 29 13
CYCLOBENZAPRINE HCL 175 68 R 30 73
ALENDRONATE SODIUM 174 168 31 26
ATENOLOL 173 127 32 18
PLAVIX 171 157 33 46
QUETIAPINE FUMARATE 165 107 34 66
ALLOPURINOL 162 140 35 35
BUSPIRONE HCL 161 119 36 91
PROMETHAZINE HCL 157 77 R 37 93
NOVOLOG 155 86 38 94
DIVALPROEX SODIUM 154 104 39 70
SPIRIVA 152 104 40 57
IBUPROFEN 150 66 41 74
JANTOVEN 149 149 42 110
CIPROFLOXACIN HCL 146 114 43 56
BACLOFEN 143 49 44 125
OXYCODONE-ACETAMINOPHEN 142 73 S2 45 32
FLUTICASONE PROPIONATE 136 63 46 42
LOSARTAN POTASSIUM 136 107 46 21
KLOR-CON M10 134 104 48 138
TAMSULOSIN HCL 131 108 49 29
LEVETIRACETAM 130 87 50 112
POLYETHYLENE GLYCOL 3350 129 96 51 55
JANUVIA 125 82 52 54
NAPROXEN 122 77 53 84
FAMOTIDINE 119 78 54 68
PAROXETINE HCL 117 103 55 60
AZITHROMYCIN 117 75 55 36
METOPROLOL SUCCINATE 116 104 57 19
OLANZAPINE 115 108 58 106
LYRICA 112 100 59 87
ACTOS 110 95 60 113
OXYBUTYNIN CHLORIDE ER 109 100 61 79
AMOX TR-POTASSIUM CLAVULANATE 108 91 62 143
DIGOXIN 108 105 62 65
ADVAIR DISKUS 107 60 64 58
LANTUS SOLOSTAR 103 58 65 80
TRICOR 101 61 66 132
SULFAMETHOXAZOLE-TRIMETHOPRIM 100 67 67 77
PANTOPRAZOLE SODIUM 99 76 68 43
NOVOLIN R 95 63 69 174
ZOLPIDEM TARTRATE 94 45 70 24
SODIUM CHLORIDE 94 32 70 199
GLYBURIDE 91 91 R 72 62
ABILIFY 87 39 73 144
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 35 74 22
LEVOFLOXACIN 84 67 75 115
RANITIDINE HCL 84 50 75 41
KLOR-CON 10 82 51 77 160
FINASTERIDE 82 58 77 92
DICYCLOMINE HCL 80 24 79 202
MELOXICAM 76 49 80 34
SEROQUEL 76 55 80 146
TRIAMTERENE-HCTZ 75 51 82 48
FLUOXETINE HCL 74 25 83 61
VENLAFAXINE HCL ER 73 65 84 103
TRAMADOL HCL-ACETAMINOPHEN 73 56 84 210
ESCITALOPRAM OXALATE 70 42 86 82
PROPRANOLOL HCL 69 68 87 136
OXYBUTYNIN CHLORIDE 69 49 87 120
HYDROXYZINE PAMOATE 68 15 R 89 218
SPIRONOLACTONE 68 52 89 75
FENTANYL 67 51 S2 91 76
EXELON 66 56 92 108
GLIPIZIDE 64 62 93 67
METOCLOPRAMIDE HCL 63 38 94 139
LIDODERM 62 49 95 122
HYDRALAZINE HCL 61 50 96 104
LOPERAMIDE 61 41 96 242
ISOSORBIDE MONONITRATE ER 60 54 98 45
NITROFURANTOIN MONO-MACRO 60 48 98 158
CELEBREX 59 50 100 89
NYSTATIN 59 42 100 149
ISOSORBIDE DINITRATE 58 49 102 232
VENLAFAXINE HCL 56 40 103 171
GENTAMICIN SULFATE 56 0 103 277
SUCRALFATE 56 26 103 164
ROPINIROLE HCL 56 33 103 88
HYDROXYZINE HCL 55 44 R 107 172
INSULIN SYRINGE 55 32 107 162
CARBIDOPA-LEVODOPA 54 54 109 97
FENOFIBRATE 54 36 109 59
FLUCONAZOLE 53 16 111 194
LOSARTAN-HYDROCHLOROTHIAZIDE 53 47 111 49
DIOVAN 53 27 111 50
RISPERIDONE 53 46 111 63
LEVEMIR 51 51 115 204
SINGULAIR 51 22 115 95
TOPIRAMATE 50 13 117 156
LIPITOR 50 35 117 100
CRESTOR 50 36 117 33
BENICAR 50 37 117 206
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.